Optimization of Primary Culture Condition for Mesenchymal Stem Cells Derived from Umbilical Cord Blood with Factorial Design

被引:28
作者
Fan, Xiubo [1 ]
Liu, Tianqing [1 ]
Liu, Yang [1 ]
Ma, Xuehu [1 ]
Cui, Zhanfeng [2 ]
机构
[1] Dalian Univ Technol, Dept Chem Engn, Dalian R&D Ctr Stem Cell & Tissue Engn, Dalian, Peoples R China
[2] Univ Oxford, Dept Engn Sci, Oxford Ctr Tissue Engn & Bioproc, Oxford OX1 3PJ, England
关键词
factorial experiment; umbilical cord blood; mesenchymal stem cells; cytokines; INHIBITS APOPTOSIS; GROWTH; PROLIFERATION; EXPANSION; EXPRESSION; SERUM; MSCS;
D O I
10.1002/btpr.68
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Mesenchymal stem cells (MSCs) can not only support the expansion of hematopoietic stem cells in vitro, but also alleviate complications and accelerate recovery of hematopoiesis during hematopoietic stem cell transplantation. However, it proved challenging to culture MSCs from umbilical cord blood (UCB) with a success rate of 20-30%. Many cell culture parameters contribute to this outcome and hence optimization of culture conditions is critical to increase the probability of success. In this work, factional factorial design was applied to study the effect of cell inoculated density, combination and dose of cytokines, and presence of serum and stromal cells. The cultured UCB-MSC-like cells were characterized by flow cytometry and their multilineage differentiation potentials were tested. The optimal protocol was identified achieving above 90% successful outcome: 2 x 10(6) cells/mL mononuclear cells inoculated in Iscove's modified Dulbecco's medium supplied with 10% FBS, 15 ng/mL IL-3, and 5 ng/mL Granulocyte-macrophage colony-stimulating factor (GM-CSF). Moreover, the UCB-MSC-like cells expressed MSC surface markers of CD13, CD29, CD105, CD166, and CD44 positively, and CD34, CD45, and human leukocyte antigens-DR (HLA-DR) negatively. Meanwhile, these cells could differentiate into osteoblasts, chondrocytes, and adipocytes similarly to MSCs derived from bone marrow. In conclusion, we have developed an efficient protocol for the primary culture of UCB-MSCs by adding suitable cytokines into the culture system. (C) 2009 American Institute of Chemical Engineers Biotechnol. Prog., 25: 499-507, 2009
引用
收藏
页码:499 / 507
页数:9
相关论文
共 50 条
  • [21] Phenotypical and functional characteristics of mesenchymal stem cells derived from equine umbilical cord blood
    N. Mohanty
    B. R. Gulati
    R. Kumar
    S. Gera
    S. Kumar
    P. Kumar
    P. S. Yadav
    Cytotechnology, 2016, 68 : 795 - 807
  • [22] Mesenchymal stem cells derived from human placenta suppress allogeneic umbilical cord blood lymphocyte proliferation
    Li, CD
    Zhang, WY
    Li, HL
    Jiang, XX
    Zhang, Y
    Tang, PH
    Mao, N
    CELL RESEARCH, 2005, 15 (07) : 539 - 547
  • [23] Mesenchymal stem cells derived from human placenta suppress allogeneic umbilical cord blood lymphocyte proliferation
    Chang Dong LI
    Wei Yuan ZHANG
    He Lian LI
    Xiao Xia JIANG
    Yi ZHANG
    Pei Hsien TANG
    Ning MAO
    Cell Research, 2005, 15 : 539 - 547
  • [24] Mesenchymal stem cells derived from human placenta suppress allogeneic umbilical cord blood lymphocyte proliferation
    Peihsien TANG
    CellResearch, 2005, (07) : 539 - 547
  • [25] The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro
    Wang, Meng
    Yang, Yuan
    Yang, Dongming
    Luo, Fei
    Liang, Wenjie
    Guo, Shuquan
    Xu, Jianzhong
    IMMUNOLOGY, 2009, 126 (02) : 220 - 232
  • [26] Immunologic properties of differentiated and undifferentiated mesenchymal stem cells derived from umbilical cord blood
    Lee, Hyo-Jong
    Kang, Kyung-Sun
    Kang, Sun-Young
    Kim, Hyung-Sik
    Park, Se-Jin
    Lee, Seung-Yong
    Kim, Kwang-Dong
    Lee, Hee-Chun
    Park, Ji-Kwon
    Paik, Won-Young
    Lee, Lyon
    Yeon, Seong-Chan
    JOURNAL OF VETERINARY SCIENCE, 2016, 17 (03) : 289 - 297
  • [27] In vitro mesengenic potential of human umbilical cord blood-derived mesenchymal stem cells
    Gang, EJ
    Hong, SH
    Jeong, JA
    Hwang, SH
    Kim, SW
    Yang, IH
    Ahn, CY
    Han, H
    Kim, H
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 321 (01) : 102 - 108
  • [28] Optimization of culture conditions for rapid clinical-scale expansion of human umbilical cord blood-derived mesenchymal stem cells
    Choi, Wankyu
    Kwon, Soon-Jae
    Jin, Hye Jin
    Jeong, Sang Young
    Choi, Soo Jin
    Oh, Wonil
    Yang, Yoon Sun
    Jeon, Hong Bae
    Jeon, Eun Su
    CLINICAL AND TRANSLATIONAL MEDICINE, 2017, 6
  • [29] Phenotypical and functional characteristics of mesenchymal stem cells derived from equine umbilical cord blood
    Mohanty, N.
    Gulati, B. R.
    Kumar, R.
    Gera, S.
    Kumar, S.
    Kumar, P.
    Yadav, P. S.
    CYTOTECHNOLOGY, 2016, 68 (04) : 795 - 807
  • [30] Good manufacturing practice-compliant isolation and culture of human umbilical cord blood-derived mesenchymal stem cells
    Phuc Van Pham
    Ngoc Bich Vu
    Vuong Minh Pham
    Nhung Hai Truong
    Truc Le-Buu Pham
    Loan Thi-Tung Dang
    Tam Thanh Nguyen
    Anh Nguyen-Tu Bui
    Ngoc Kim Phan
    Journal of Translational Medicine, 12